Patents by Inventor Benjamin Doranz

Benjamin Doranz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12497450
    Abstract: Antibodies and compositions against Claudin 6 and uses thereof are provided.
    Type: Grant
    Filed: January 4, 2022
    Date of Patent: December 16, 2025
    Assignee: Integral Molecular, Inc.
    Inventors: Ross Chambers, Joseph Rucker, Thomas Charpentier, Lewis J. Stafford, Brad Screnci, Trevor Barnes, Benjamin Doranz
  • Publication number: 20250129154
    Abstract: Antibodies and compositions against Claudin 6 and uses thereof are provided.
    Type: Application
    Filed: December 23, 2024
    Publication date: April 24, 2025
    Inventors: Ross CHAMBERS, Joseph RUCKER, Thomas CHARPENTIER, Lewis J. STAFFORD, Brad SCRENCI, Trevor BARNES, Benjamin DORANZ
  • Publication number: 20220127355
    Abstract: Antibodies and compositions against Claudin 6 and uses thereof are provided.
    Type: Application
    Filed: January 4, 2022
    Publication date: April 28, 2022
    Inventors: Ross CHAMBERS, Joseph RUCKER, Thomas CHARPENTIER, Lewis J. STAFFORD, Brad SCRENCI, Trevor BARNES, Benjamin DORANZ
  • Patent number: 11248046
    Abstract: Antibodies and compositions against Claudin 6 and uses thereof are provided.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: February 15, 2022
    Assignee: Integral Molecular, Inc.
    Inventors: Ross Chambers, Joseph Rucker, Thomas Charpentier, Lewis J. Stafford, Brad Screnci, Trevor Barnes, Benjamin Doranz
  • Publication number: 20200262915
    Abstract: Antibodies and compositions against Claudin 6 and uses thereof are provided.
    Type: Application
    Filed: February 13, 2020
    Publication date: August 20, 2020
    Inventors: Ross Chambers, Joseph Rucker, Thomas Charpentier, Lewis J. Stafford, Brad Screnci, Trevor Barnes, Benjamin Doranz
  • Patent number: 9902765
    Abstract: Embodiments disclosed herein provide for antibodies, including neutralizing antibodies, against Chikungunya virus, uses thereof, and methods of identifying antibodies, including neutralizing antibodies, against Chikungunya virus. In some embodiments, antibodies that binds to a CHIKV antigen, wherein the antigen is the CHIKV E1, E2, E3 protein, or any heterocomplex thereof are provided. In some embodiments, the antibody is an isolated antibody, a neutralizing antibody, a recombinant antibody, or any combination thereof. In some embodiments, the antibodies described herein bind to an epitope of E2 Domain A, E2 Domain B, or E1 Domain II of the CHIKV antigen. In some embodiments, the antigen is E2 protein.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: February 27, 2018
    Assignees: INTEGRAL MOLECULAR, INC., BLOOD SYSTEMS RESEARCH INSTITUTE
    Inventors: Benjamin Doranz, Kimberly-Anne Mattia, Kristen Kahle, Graham Simmons, Rachel Hua-Ning Fong, Soma Banik Banerjee
  • Publication number: 20160145323
    Abstract: Embodiments disclosed herein provide for antibodies, including neutralizing antibodies, against Chikungunya virus, uses thereof, and methods of identifying antibodies, including neutralizing antibodies, against Chikungunya virus. In some embodiments, antibodies that binds to a CHIKV antigen, wherein the antigen is the CHIKV E1, E2, E3 protein, or any heterocomplex thereof are provided. In some embodiments, the antibody is an isolated antibody, a neutralizing antibody, a recombinant antibody, or any combination thereof. In some embodiments, the antibodies described herein bind to an epitope of E2 Domain A, E2 Domain B, or E1 Domain II of the CHIKV antigen. In some embodiments, the antigen is E2 protein.
    Type: Application
    Filed: July 21, 2014
    Publication date: May 26, 2016
    Inventors: Benjamin DORANZ, Kimberly-Anne MATTIA, Kristen KAHLE, Graham SIMMONS
  • Publication number: 20110077163
    Abstract: The present invention relates to articles and methods for determining the function of genes, gene products, and nucleic acid products. The present invention also relates to identifying ligands and binding partners or proteins and nucleic acid products. The present invention also relates to methods and compositions related to reverse-transfection.
    Type: Application
    Filed: September 28, 2010
    Publication date: March 31, 2011
    Applicant: INTEGRAL MOLECULAR, INC.
    Inventor: Benjamin Doranz
  • Publication number: 20080070800
    Abstract: Articles and methods are provided for determining the function of genes in a rapid and cost effective manner. Nucleic acids are arrayed upon a substrate. In accordance with certain preferred embodiments, viable cells are subsequently caused to be bound to the substrate at the locations occupied by the nucleic acids. Subsequent transduction or transfection of the cells by the nucleic acids followed by continued vitality of the cells permits expression of the proteins encoded by the respected nucleic acids. Knowledge of the identity of the nucleic acids, at least as regards their locations on the substrate, permits determination of protein function thereof. Methods of creating and using such cell-arrays, and methods of reverse-transfection and reverse-transduction are featured.
    Type: Application
    Filed: September 11, 2007
    Publication date: March 20, 2008
    Inventor: Benjamin Doranz
  • Publication number: 20070225227
    Abstract: The present invention relates to the use of lipoparticles, virus-like particles, and viruses. The present invention also relates to testing ion channel function and modulators of ion channels.
    Type: Application
    Filed: January 25, 2007
    Publication date: September 27, 2007
    Applicant: Integral Molecular, Inc.
    Inventor: Benjamin Doranz
  • Publication number: 20070111201
    Abstract: The present invention relates to articles and methods for determining the function of genes, gene products, and nucleic acid products. The present invention also relates to identifying ligands and binding partners or proteins and nucleic acid products. The present invention also relates to methods and compositions related to reverse-transfection.
    Type: Application
    Filed: September 8, 2005
    Publication date: May 17, 2007
    Inventor: Benjamin Doranz
  • Publication number: 20050123563
    Abstract: The present invention relates to lipoparticles. The invention also relates to producing lipoparticles. The invention further relates to lipoparticles comprising a viral structural protein. The invention further relates to a lipoparticle comprising a membrane protein, and the lipoparticle can be attached to a sensor surface. The invention further relates to methods of producing and using the lipoparticle to, inter alia, assess protein binding interactions.
    Type: Application
    Filed: July 28, 2004
    Publication date: June 9, 2005
    Inventors: Benjamin Doranz, Sharon Willis, Eric Ross, Tiffani Greene